2:00min
When a patient walked into Jason Dhana’s practice with a clear case of preseptal cellulitis, he knew exactly what was needed: prompt treatment with oral antibiotics. But as is the case for many optometrists in Australia, Jason’s next step wasn’t to treat – it was to refer.
This is the daily reality for many therapeutically endorsed optometrists across the country, who have the skills and training to diagnose and manage these types of eye conditions but are held back by outdated prescribing restrictions.
That’s why Optometry Australia is calling on the Optometry Board of Australia to review and update the Guidelines for the Use of Scheduled Medicines, to enable therapeutically endorsed optometrists to prescribe oral medications for the purpose of the practice of optometry.
For Jason, a New Zealand-trained optometrist now practising in Sydney, the contrast is stark. In New Zealand, prescribing oral medications is a standard part of the role, but in Australia, it’s a roadblock.
In a conversation with Optometry Australia, Jason shares his insights on what this reform could mean for patients, the profession and the primary healthcare system as a whole – and why it’s time for Australia to catch up.
Q: What kind of impact can a delay in treatment have when optometrists can’t prescribe oral medications?
Jason: While practicing in Australia, I once saw a patient with a clear-cut case of preseptal cellulitis. The condition was mild but required immediate oral antibiotics to prevent progression to orbital cellulitis. I had diagnosed the case confidently, based on history, clinical presentation and exclusion of red flags – but I had to refer the patient to their GP for treatment. Unfortunately, that resulted in a delay of more than 24 hours due to limited appointment availability, during which time the swelling worsened. In contrast, if I were practicing in New Zealand, I could have started treatment immediately, preventing progression and potentially reducing the need for further medical intervention.
Q: How would the outcome of this case have changed had you been able to prescribe the necessary oral medicines?
Jason: The patient could have left the consult with a script in hand and started treatment within the hour. I believe the infection would have resolved more rapidly and with less risk of progression or complications. Additionally, the patient would have avoided the frustration and cost of an additional appointment. It would have also alleviated pressure on already overstretched general practices. As optometrists, we are trained to identify and differentiate between conditions requiring topical versus systemic therapy. When we are confident in our diagnosis and management plan, it’s frustrating to be unable to follow through.
Q: What kinds of patients stand to benefit most from this change and why?
Jason: Rural and remote patients, time-poor individuals, underserved communities and those with mobility issues stand to benefit significantly. The ability for optometrists to prescribe oral medications would reduce the burden on GPs and emergency departments, particularly in areas with limited access to healthcare providers. Additionally, patients presenting with acute infections or inflammation could begin treatment sooner, which can prevent escalation and reduce complications. It’s also more cost-effective and convenient for the patient; they won’t have to schedule a second appointment just to receive a prescription for something the optometrist already identified.
Q: How would oral prescribing change your day-to-day practice?
Jason: It would streamline patient care immensely. Currently, I spend time writing referral letters for conditions I’m fully competent to manage, knowing it will delay the start of treatment. Oral prescribing would reduce unnecessary referrals, free up appointments with GPs or ophthalmologists, and lower healthcare system load overall. It would also give patients more confidence in the care they’re receiving, knowing they’re being treated immediately and appropriately by someone who specialises in eye care.
Q: Has your training, education and experience equipped you to prescribe oral medicines for the practice of optometry?
Jason: Absolutely. In New Zealand, I trained and still practice under full scope, which includes prescribing oral medications, independently, within a hospital emergency setting. My training and subsequent experience has taught me not only how to prescribe but also when not to – and when to refer or seek advice. I approach prescribing with clinical caution and evidence-based judgement.
Q: Colleagues in New Zealand, the UK, and the US have had oral prescribing rights for years. What lessons do you think Australia can take from their experience?
Jason: Optometrists can be trusted with this responsibility. In New Zealand, we’ve had oral prescribing rights since 2014! The model works well; optometrists are respected as primary eye care providers, and oral prescribing helps us manage more cases independently. The result is a more efficient, collaborative healthcare system. These countries show that with training and appropriate regulation, oral prescribing does not increase risk – it enhances access to care and improves outcomes.
Australia has the opportunity to implement this safely, using existing international frameworks as a guide. Under the Trans-Tasman Mutual Recognition Agreement (TTMRA), Australian optometrists can register and practise in New Zealand with minimal barriers, and vice versa, based on the shared recognition that both countries uphold equivalent professional standards. This means that an Australian-trained optometrist who is not permitted to prescribe oral medications in Australia can move to New Zealand, register almost immediately, and legally begin prescribing oral medications – without undertaking any additional training, exams, or regulatory hurdles. This presents a clear inconsistency: if the qualifications and training are deemed sufficient for oral prescribing in New Zealand, why are those same skills not considered safe or adequate within Australia?
It undermines the argument that Australian optometrists are not ready to expand their prescribing rights and introduces a discrepancy in how public safety is regulated between the two nations. It also creates professional inequality; whereby Australian optometrists are trusted to practise to a higher scope overseas than in their own country. The existence of this loophole via the TTMRA only strengthens the case for reform, clearly demonstrating that the profession is already equipped for oral prescribing and that the current restrictions are outdated and out of step with international standards.
Q: Have you worked in or observed systems where optometrists can prescribe oral medications?
Jason: Yes, my New Zealand hospital clinical work allows full oral prescribing. The difference is night and day. I can manage conditions holistically, with one appointment, one clinician, and a comprehensive management plan. Patients appreciate not having to go through multiple providers. From a professional standpoint, it’s fulfilling to practice at full scope and know you’re delivering complete care. In Australia, it’s frustrating to identify the right treatment but have to rely on someone else to write the script. I know how the older generation of optometrists now felt before we had topical prescribing rights. They would’ve sent patients to their GP for treatment of bacterial conjunctivitis! This is the exact same situation happening all over again, and hopefully one day soon we will again be on the other side of history.
Q: What drives your passion for progressing this reform?
Jason: I’ve seen how effective and efficient full-scope optometry is, particularly in hospital settings and underserved communities in both Australia and New Zealand. I’m passionate about advancing our profession so we can provide care where and when it’s needed most. I also see the potential for a better-integrated healthcare system where optometrists are empowered to work to their full potential. This isn’t about doing more for the sake of it – it’s about making the patient experience safer, quicker and more effective. Optometrists are ready for this next step.
Help us strengthen the case for oral prescribing rights
We’re seeking your stories to help demonstrate why oral prescribing rights matter for optometrists and the patients you care for. If you’ve encountered a situation where your ability to prescribe oral medications would have made a difference, we’d love to hear from you. Reach out to our advocacy team at policy@optometry.org.au.
Tagged as: advocacy, Scope of practice, Therapeutics